Wild S, Roglie G, Green A. Global prevalence of diabetes [J]. Diabetes Care, 2004(5):1047.
|
BULT MJ, AN DALEN T, MULLER AF. Surgical treatment of obesity [J]. European Journal of Endocrinology, 2008(2):135.
|
Adams T D, Gress R E, Smith S C. Long-term mortality after gastric bypass surgery [J]. New England Journal of Medicine, 2007.753.
|
Wittgrove, Wesley Clark. Laparoscopic gastric bypass.Roux-en-Y:Preliminary report of five cases [J]. Obesity Surgery, 1994(4):353.
|
Cummings D E, Overdun J. Gastric bypass for obesity:mecganisms of weisht loss and diabetes resolution [J]. JClin Endocri Metab, 2004(6):2608.
|
Scopinaro N. Biliopancreatic diversion:mechanisms of action and long-term results [J]. Obesity Surgery, 2006.683.
|
Mottin C C, Vontobel Padoin A, Schroer C E. Behavior of type 2 diabetes mellitus in morbid obese patients submitted to gastric bypass [J]. Obesity Surgery, 2008(2):179.
|
Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS).Report:Asian Consensus Meeting on Metaboilc Surgery.Recommendations for the use of Bariatric and Gastrointestinal Metaboilc Surgery for Treatment of Obesity and Type Ⅱ Diabetes Mellitus in the Asian Population.9th and 10th, 2008, Trivandrum India [J]. Obesity Surgery, 2010.929.
|
Lee W J, Wang W. Bariatric surgery:Asia-pacific perspective [J]. Obesity Surgery, 2005(6):751.
|
American Diabetes Association. Standards of medical care in diabetes-2011 [J]. Diabetes Care, 2011, (1):S11.doi: 10.3969/j.issn.1672-7851.2011.01.003.
|
Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obcsc aninml model of type 2 diabetes; a new perspective for an old dlsease [J]. Annals of Surgery, 2004(1):1.
|
Scopinaro N, Adami G F, Papadia F S. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 [J]. Annals of Surgery, 2011.699.
|
Schauer P R, Burguera B, IkrarnuddinS. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus [J]. Annals of Surgery, 2003(4):467.
|
Mason EE. Ileal[correction of ilial]transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery [J]. Obesity Surgery, 1999(3):223.
|
Patfiti A, Facchiano E, Annetti C. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model [J]. Obesity Surgery, 2005(9):1258.
|
MEIRELLES K, AHMED T, DEREK M. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat [J]. Annals of Surgery, 2009(2):277.
|
Winzell MS, Nogueiras R, Dieguez C. Dual action of adiponectin on insulin secretion in insulin-resistant mice [J]. Biochemical and Biophysical Research Communications, 2004(1):154.
|
MIYAWAKI K, YAMADA Y, BAN N. nhibition of gastric inhibitory polypeptide signaling prevents obesity [J]. Nature Medicine, 2002(7):738.
|
FLATT P R. Effective surgical treatment of obesity may be mediated by ablation of the lipegenic gut hormone gastric inhibitory polypeptide(GIP):evidence and clinical opportunity for development of new obesity-diabetes drugs [J]. Diab Vasc Dis Res, 2007(2):151.
|
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus [J]. Annals of Surgery, 2002(5):554.
|
Rubino F, Gagner M, Gentileschi P. The early effect of the Roux-en-Ygastric bypass on hormones involved in body weight and glucose metabolism [J]. Annals of Surgery, 2004(2):236.
|
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus [J]. Annals of Surgery, 2002(5):554.
|
Moo T A, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes [J]. Curr Opin Endocrinol Diabetes Obes, 2008(2):153.
|
Bahhio L L, Drucker D J. Biology of incretins:GLP-1 and GIP [J]. Gastroenterology, 2007(6):2131.
|
Drucker D J. Glucagon-like peptide-1 and the islet beta-cell:augmentation0f cell proliferation and inhibition of apoptosis [J]. Endocrinology, 2003, (12):5145.
|
Service G J, Thompaen G B, Service F J. Hyperinsuline-mic hypoglycemis with neaidioblastosis after gastric-bypass surgery [J]. New England Journal of Medicine, 2005(3):249.
|